153 related articles for article (PubMed ID: 28852480)
21. Nephrotic syndrome caused by membranous nephropathy: response to a short course of cyclophosphamide alternating with prednisolone.
Fujimoto S; Hara S; Sato Y; Yamada K; Hisanaga S; Eto T
Intern Med; 2004 Jan; 43(1):30-4. PubMed ID: 14964576
[TBL] [Abstract][Full Text] [Related]
22. Effective treatment administration of cyclophosphamide in membranous nephropathy.
Dede F; Ayili D; Sahiner S
J Nephrol; 2008; 21(4):560-5. PubMed ID: 18651546
[TBL] [Abstract][Full Text] [Related]
23. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
[TBL] [Abstract][Full Text] [Related]
24. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
[TBL] [Abstract][Full Text] [Related]
25. Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study.
Liu S; Li X; Li H; Liang Q; Chen J; Chen J
BMC Nephrol; 2015 Dec; 16():200. PubMed ID: 26637482
[TBL] [Abstract][Full Text] [Related]
26. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM; Wong SC; Willis NS; Craig JC
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of tacrolimus-based treatment for nephrotic idiopathic membranous nephropathy in young adults: A retrospective study.
Zhang XJ; Ji CF; Yuan JZ; Wang L; Zhang J; Fang W; Bai DF; Hu Z
Kaohsiung J Med Sci; 2019 Oct; 35(10):633-639. PubMed ID: 31225949
[TBL] [Abstract][Full Text] [Related]
28. Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy.
Matsumoto H; Nagaoka Y; Okada T; Wada T; Gondo A; Esaki S; Hayashi A; Miyaoka Y; Nakao T
Intern Med; 2011; 50(18):1905-10. PubMed ID: 21921367
[TBL] [Abstract][Full Text] [Related]
29. [The clinical efficacy and safety of modified Ponticelli regimen for treatment of idiopathic membranous nephropathy].
Xia W; Pei H; Li S; Fu S; Tian L
Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):181-5. PubMed ID: 26926368
[TBL] [Abstract][Full Text] [Related]
30. Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.
McQuarrie EP; Stirling CM; Geddes CC
Nephrol Dial Transplant; 2012 Jan; 27(1):235-42. PubMed ID: 21558430
[TBL] [Abstract][Full Text] [Related]
31. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
32. A 10-year follow-up of idiopathic membranous nephropathy patients on steroids and cyclophosphamide: a case series.
Ram R; Guditi S; Kaligotla Venkata D
Ren Fail; 2015 Apr; 37(3):452-5. PubMed ID: 25594615
[TBL] [Abstract][Full Text] [Related]
33. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
Chan TM; Li FK; Wong RW; Wong KL; Chan KW; Cheng IK
Nephron; 1995; 71(3):321-7. PubMed ID: 8569982
[TBL] [Abstract][Full Text] [Related]
34. Treatment of renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone.
Brown JH; Douglas AF; Murphy BG; Hill CM; McNamee PT; Nelson WE; Doherty CC
Nephrol Dial Transplant; 1998 Feb; 13(2):443-8. PubMed ID: 9509460
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome of patients with idiopathic membranous nephropathy.
Ríhová Z; Merta M; Maixnerová D; Honsová E; Reiterová J; Rysavá R; Zabka J; Tesar V
Prague Med Rep; 2006; 107(2):189-98. PubMed ID: 17066739
[TBL] [Abstract][Full Text] [Related]
36. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
[TBL] [Abstract][Full Text] [Related]
37. A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis.
Müller-Deile J; Schiffer L; Hiss M; Haller H; Schiffer M
Eur J Clin Invest; 2015 Dec; 45(12):1260-9. PubMed ID: 26444294
[TBL] [Abstract][Full Text] [Related]
38. Restrictive use of immunosuppressive treatment in patients with idiopathic membranous nephropathy: high renal survival in a large patient cohort.
du Buf-Vereijken PW; Feith GW; Hollander D; Gerlag PG; Wirtz JJ; Noordzij TC; Wetzels JF;
QJM; 2004 Jun; 97(6):353-60. PubMed ID: 15152109
[TBL] [Abstract][Full Text] [Related]
39. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
Rauen T; Fitzner C; Eitner F; Sommerer C; Zeier M; Otte B; Panzer U; Peters H; Benck U; Mertens PR; Kuhlmann U; Witzke O; Gross O; Vielhauer V; Mann JFE; Hilgers RD; Floege J
J Am Soc Nephrol; 2018 Jan; 29(1):317-325. PubMed ID: 29042456
[TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]